GENESIS Ventures

Renalyse is a biotechnology company specializing in the development of medical platforms. It focuses on creating point-of-care, decentralized diagnostic devices for monitoring chronic kidney disease at home and in primary care settings.

Corify Care is a Madrid-based developer of non-invasive medical technology for cardiac arrhythmias, focusing on atrial fibrillation. The company creates a device that can visualize the heart's electrical activity without catheters or invasive imaging, enabling real-time electrocardiographic imaging and electro-anatomical mapping during routine cardiology visits. Its ACORYS system addresses limitations of existing methods by providing activation patterns at multiple points of the heart to help clinicians identify a patient-specific origin of atrial fibrillation and guide treatment decisions non-invasively. Founded in 2019, Corify Care aims to improve clinical management of arrhythmias through accessible, non-surgical mapping that supports safer, faster diagnosis and planning.

ABLE Human Motion is a Barcelona-based medical device company founded in 2018. It specializes in developing robotic exoskeletons, with its flagship product being the ABLE Exoskeleton. This wearable technology actively assists paraplegic individuals to stand up, walk, and sit down, aiming to enhance rehabilitation efficiency for clinicians and empower users with greater mobility and independence.

Mowoot is a company that specializes in developing wearable medical devices aimed at improving the quality of life for individuals suffering from chronic constipation. Founded in 2014 and based in Barcelona, Spain, Mowoot offers a non-pharmacological and non-invasive solution that simulates a manual abdominal massage performed by healthcare professionals. Utilizing advanced pneumatic technology, its device provides automatic colon-specific massages to stimulate intestinal transit, thereby helping to treat and prevent chronic slow transit constipation without the need for colon cleansing supplements, enemas, or laxatives. Mowoot emerged from the MOEBIO dHEALTH program, drawing inspiration from concepts in design and business innovation.

Quality Pharma specializes in developing AI-powered medication evaluation tools, notably its proprietary QS System® (Quantum Satis). This software employs algorithm-driven analysis to identify potential adverse drug events in patients taking multiple medications (polypharmacy), flagging issues such as inappropriate drugs, drug duplication, interactions, and undertreatment. The system offers modules for analysis, monitoring, and evaluation, serving healthcare professionals and empowering individuals with a user-friendly interactive version. Its primary goal is to enhance elderly patient health by optimizing medication use and preventing drug-related problems.

NeuroHeal is a spinout from the Institut of Neurosciences from the Autonomous University of Barcelona.

ADmit Therapeutics is a biotechnology company that develops diagnostic tests for early detection of Alzheimer’s disease. Its blood-based assay uses epigenetic analysis to assess mitochondrial DNA methylation, including methylcytosines, through next-generation sequencing, and does not rely on beta-amyloid or tau markers. The test is intended to aid pharmaceutical research by enabling early diagnosis and streamlined drug development. The company was founded in 2017 and is based in Begues, Spain.